Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Debt to Equity (2016 - 2026)

Conmed filings provide 17 years of Debt to Equity readings, the most recent being $0.85 for Q1 2026.

  • On a quarterly basis, Debt to Equity fell 7.3% to $0.85 in Q1 2026 year-over-year; TTM through Mar 2026 was $0.85, a 7.3% decrease, with the full-year FY2025 number at $0.81, down 14.1% from a year prior.
  • Debt to Equity hit $0.85 in Q1 2026 for Conmed, up from $0.81 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.46 in Q2 2022 to a low of $0.81 in Q4 2025.
  • Median Debt to Equity over the past 5 years was $1.1 (2024), compared with a mean of $1.11.
  • Biggest five-year swings in Debt to Equity: surged 62.31% in 2022 and later dropped 21.28% in 2025.
  • Conmed's Debt to Equity stood at $1.41 in 2022, then dropped by 17.49% to $1.17 in 2023, then fell by 19.4% to $0.94 in 2024, then fell by 14.1% to $0.81 in 2025, then rose by 4.67% to $0.85 in 2026.
  • The last three reported values for Debt to Equity were $0.85 (Q1 2026), $0.81 (Q4 2025), and $0.85 (Q3 2025) per Business Quant data.